Jun 23, 2022
On this episode, we discuss the treatment options available for managing an H. pylori infection. We discuss how resistance rates have changed the recommended first-line options, and we cover the new combo paks that utilize vonoprazan (a potassium-competitive acid blocker) for acid suppression.
Thanks for listening!
We want to give a big thanks to our main sponsor Pyrls. Try out their drug information app today. Visit the website below for a free trial:
If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. You can find our account at the website below:
If you have any questions for Cole or me, reach out to us on any of the following:
Text - 415-943-6116
Mike - email@example.com
Cole - firstname.lastname@example.org
Instagram and other social media platforms - @corconsultrx
This podcast reviews current evidence-based medicine and pharmacy treatment options. This podcast is intended to be used for educational purposes only and is intended for healthcare professionals and students. This podcast is not for patients and not intended as advice or treatment.